Literature DB >> 20486204

Serum prolidase enzyme activity and its relation to histopathological findings in patients with non-alcoholic steatohepatitis.

Mehmet Horoz1, Mehmet Aslan, Fusun F Bolukbas, Cengiz Bolukbas, Yasar Nazligul, Hakim Celik, Nurten Aksoy.   

Abstract

The aim of this study was to investigate serum prolidase enzyme activity and to find out its association with liver biopsy specimens' histopathological findings in patients with nonalcoholic steatohepatitis (NASH), which may progress to liver fibrosis and cirrhosis. Thirty-six patients with biopsy-proven NASH and 29 healthy controls were enrolled. Serum prolidase enzyme activity was measured spectrophotometrically. Serum prolidase enzyme activity was significantly higher in patients with NASH than controls (P=0.016). A significant correlation was observed between serum prolidase enzyme activity and fibrosis score in patients with NASH (r=0.661, P<0.001). Serum prolidase activity seems to be correlated with the level of fibrosis. Monitoring serum prolidase activity may be a useful adjunctive tool in predicting liver fibrosis, especially in the absence of advanced fibrosis and other conditions, which may affect the interpretation of prolidase activity. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20486204      PMCID: PMC6647739          DOI: 10.1002/jcla.20334

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  34 in total

1.  Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis.

Authors:  A Parés; R Deulofeu; A Giménez; L Caballería; M Bruguera; J Caballería; A M Ballesta; J Rodés
Journal:  Hepatology       Date:  1996-12       Impact factor: 17.425

2.  Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia.

Authors:  V Ratziu; P Giral; M Munteanu; D Messous; A Mercadier; M Bernard; R Morra; F Imbert-Bismut; E Bruckert; T Poynard
Journal:  Aliment Pharmacol Ther       Date:  2007-01-15       Impact factor: 8.171

3.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

Review 4.  Review article: the role of inflammation in the pathogenesis of gastric cancer.

Authors:  P Ernst
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

5.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study.

Authors:  J Foucher; E Chanteloup; J Vergniol; L Castéra; B Le Bail; X Adhoute; J Bertet; P Couzigou; V de Lédinghen
Journal:  Gut       Date:  2005-07-14       Impact factor: 23.059

6.  Serum markers detect the presence of liver fibrosis: a cohort study.

Authors:  William M C Rosenberg; Michael Voelker; Robert Thiel; Michael Becka; Alastair Burt; Detlef Schuppan; Stefan Hubscher; Tania Roskams; Massimo Pinzani; Michael J P Arthur
Journal:  Gastroenterology       Date:  2004-12       Impact factor: 22.682

7.  Plasma prolidase and prolinase activity in alcoholic liver disease.

Authors:  B Brosset; I Myara; M Fabre; A Lemonnier
Journal:  Clin Chim Acta       Date:  1988-07-29       Impact factor: 3.786

8.  Outcome of patients hospitalized for complications after outpatient liver biopsy.

Authors:  C H Janes; K D Lindor
Journal:  Ann Intern Med       Date:  1993-01-15       Impact factor: 25.391

9.  Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

Authors:  J Ludwig; T R Viggiano; D B McGill; B J Oh
Journal:  Mayo Clin Proc       Date:  1980-07       Impact factor: 7.616

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  11 in total

1.  Serum prolidase levels in Graves' disease without ophthalmopathy and its association with oxidative status.

Authors:  H Korkmaz; S Tabur; M Ozkaya; E Oguz; N Aksoy; E Akarsu
Journal:  J Endocrinol Invest       Date:  2015-04-22       Impact factor: 4.256

2.  Prolidase and oxidative stress in chronic hepatitis C.

Authors:  Fazilet Duygu; Suda Tekin Koruk; Hasan Karsen; Nurten Aksoy; Abdullah Taskin; Melek Hamidanoglu
Journal:  J Clin Lab Anal       Date:  2012-07       Impact factor: 2.352

3.  Evaluation of the utility of serum prolidase as a marker for liver fibrosis.

Authors:  John C Stanfliet; Michael Locketz; Peter Berman; Tahir S Pillay
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

4.  Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.

Authors:  Sevil Uygun Ilikhan; Muammer Bilici; Hatice Sahin; Ayşe Semra Demir Akca; Murat Can; Ibrahim Ilker Oz; Berrak Guven; M Cagatay Buyukuysal; Yucel Ustundag
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

5.  Prolidase could act as a diagnosis and treatment mediator in lung fibrosis.

Authors:  Ibrahim Türkbeyler; Tuncer Demir; Yavuz Pehlivan; Davut Sinan Kaplan; Ali Osman Ceribasi; Mustafa Orkmez; Nurten Aksoy; Seyithan Taysi; Bunyamin Kisacik; Ahmet Mesut Onat
Journal:  Inflammation       Date:  2012-10       Impact factor: 4.092

6.  Serum prolidase level in ankylosing spondylitis: low serum levels as a new potential gold standard biomarker for disease activity.

Authors:  Sevgi Baspinar; Mehmet Kırnap; Osman Baspınar; Oguzhan Sıtkı Dizdar; Derya Kocer
Journal:  Rheumatol Int       Date:  2016-07-21       Impact factor: 2.631

7.  The Value of Serum Prolidase Activity in Progression of Microalbuminuria in Patients With Type 2 Diabetes Mellitus.

Authors:  Tevfik Sabuncu; Omer Boduroglu; Mehmet Ali Eren; Ayse Nur Torun; Nurten Aksoy
Journal:  J Clin Lab Anal       Date:  2015-12-14       Impact factor: 2.352

8.  Serum prolidase activity, oxidant and antioxidant status in nonulcer dyspepsia and healthy volunteers.

Authors:  Shweta Kumari; Akhilesh Kumar Verma; Sumit Rungta; Rahul Mitra; Ragini Srivastava; Narender Kumar
Journal:  ISRN Biochem       Date:  2013-10-29

9.  Prolidase activity in chronic plaque psoriasis patients.

Authors:  Hacer Altın Sürücü; Nurten Aksoy; Orhan Ozgöztas; Hatice Sezen; Yavuz Yesilova; Enver Turan
Journal:  Postepy Dermatol Alergol       Date:  2015-03-30       Impact factor: 1.837

10.  Cordyceps cicadae induces G2/M cell cycle arrest in MHCC97H human hepatocellular carcinoma cells: a proteomic study.

Authors:  Hualin Wang; Jing Zhang; Wai-Hung Sit; Chung-Yung Jetty Lee; Jennifer Man-Fan Wan
Journal:  Chin Med       Date:  2014-05-08       Impact factor: 5.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.